Our findings suggest that VPA can increase the expression of NKG2D ligands in glioblastoma cells at the protein and mRNA levels, making them more susceptible to NKG2D CAR T cell-mediated immune attack in vitro and in vivo. Here, KLRK1 is linked to glioblastoma.